Toxoplasma gondii is a widespread protozoan parasite of wild, domestic, and companion animals that also commonly infects humans. Severe infections are normally only found in immunocompromised patients, including HIV infection, cancer chemotherapy, organ transplant, or infants infected in utero. However, emerging studies indicate that severe ocular toxoplasmosis can also occur in healthy adults, and that chronic infection is an underlying risk factor for some forms of psychiatric disease. Toxoplasma isolates differ dramatically in their virulence in animal models and also in human infections. Recent findings reveal that the major virulence determinants of this parasite are secretory proteins derived from the rhoptries (ROPs), which are injected to the host cell at the time of invasion. Many ROPs contain a conserved serine / threonine kinase domain and while most appear not to be active, several contain a conserved catalytic triad and have been shown to function as kinases. In preliminary studies, we have developed biochemical assays to examine the ability of ROP kinases to phosphorylate a variety of substrates in vitro. In the proposed studies, proteomic, biochemical, mass spectrometry, and bioinformatic analyses will be used to identify substrates of ROP kinases in infected host cells. These studies will provide insight into the mechanism of enhanced virulence conferred by ROP kinases. In vitro kinase assays will be further optimized to provide high-throughput screening for specific inhibitors of ROP kinases. We will also will solve the crystal structure of key members of the ROP kinase family and use molecular modeling to examine specific interactions with inhibitors. Compounds discovered though this process will be analyzed for their potential to prevent infection in vivo using the mouse model. These studies will help define the substrate specificity and inhibitor profile of an important class of parasite virulence factors and may lead to improved therapeutic intervention against toxoplasmosis.

Public Health Relevance

Toxoplasma gondii is an important food borne pathogen of humans that causes disease in those with weakened immune systems. Our studies are designed to identify new chemical inhibitors that counteract the parasite's major virulence factors. Such inhibitors may lead to improved therapeutic intervention against severe infections caused by this parasite.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI082423-02
Application #
7849934
Study Section
Drug Discovery and Mechanisms of Antimicrobial Resistance Study Section (DDR)
Program Officer
Rogers, Martin J
Project Start
2009-06-01
Project End
2011-07-31
Budget Start
2010-06-01
Budget End
2011-07-31
Support Year
2
Fiscal Year
2010
Total Cost
$379,301
Indirect Cost
Name
Washington University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Shen, Bang; Brown, Kevin; Long, Shaojun et al. (2017) Development of CRISPR/Cas9 for Efficient Genome Editing in Toxoplasma gondii. Methods Mol Biol 1498:79-103
Jones, Nathaniel G; Wang, Qiuling; Sibley, L David (2017) Secreted protein kinases regulate cyst burden during chronic toxoplasmosis. Cell Microbiol 19:
Behnke, Michael S; Dubey, J P; Sibley, L David (2016) Genetic Mapping of Pathogenesis Determinants in Toxoplasma gondii. Annu Rev Microbiol 70:63-81
Simpson, Catherine; Jones, Nathaniel G; Hull-Ryde, Emily A et al. (2016) Identification of small molecule inhibitors that block the Toxoplasma gondii rhoptry kinase ROP18. ACS Infect Dis 2:194-206
Lorenzi, Hernan; Khan, Asis; Behnke, Michael S et al. (2016) Local admixture of amplified and diversified secreted pathogenesis determinants shapes mosaic Toxoplasma gondii genomes. Nat Commun 7:10147
Behnke, Michael S; Khan, Asis; Lauron, Elvin J et al. (2015) Rhoptry Proteins ROP5 and ROP18 Are Major Murine Virulence Factors in Genetically Divergent South American Strains of Toxoplasma gondii. PLoS Genet 11:e1005434
Shen, Bang; Brown, Kevin M; Lee, Tobie D et al. (2014) Efficient gene disruption in diverse strains of Toxoplasma gondii using CRISPR/CAS9. MBio 5:e01114-14
Etheridge, Ronald D; Alaganan, Aditi; Tang, Keliang et al. (2014) The Toxoplasma pseudokinase ROP5 forms complexes with ROP18 and ROP17 kinases that synergize to control acute virulence in mice. Cell Host Microbe 15:537-50
Fleitz, Antoine; Nieves, Edward; Madrid-Aliste, Carlos et al. (2013) Enhanced detection of multiply phosphorylated peptides and identification of their sites of modification. Anal Chem 85:8566-76
Fentress, Sarah J; Steinfeldt, Tobias; Howard, Jonathan C et al. (2012) The arginine-rich N-terminal domain of ROP18 is necessary for vacuole targeting and virulence of Toxoplasma gondii. Cell Microbiol 14:1921-33

Showing the most recent 10 out of 17 publications